Altered 3D Structure of Human Tryptophan Hydroxylase-2 Caused by Change in the amino acid 341: In Silico Analysis

Abstract

Introduction Neuropsychiatric syndromes have an important connection with disorders in the regulation of serotonin, with human tryptophan hydroxylase-2 being one of the related biosynthetic enzymes of this neurotransmitter. Evidence-based genetic studies suggest a possible involvement of this enzyme in neuropsychiatric disorders caused by abnormalities in the synthesis and regulation of serotonin.

Objective To analyze the structural effects of single nucleotide polymorphism (SNP) in the enzyme tryptophan hydroxylase-2 and the changes that lead to functional alterations.

Materials and Methods In this study, we performed an in silico analysis of SNPs associated with abnormal folding of the tryptophan hydroxylase-2 protein. Different programs were used to identify amino acid changes evidencing pathogenic effects and possible functional impairments.

Results A change in the amino acid 341 (lysine [L]for phenylalanine [F]) (L341F) of the protein chain affects the total enthalpy of the protein. The enthalpy turned positive due to the energy required for the amino acid to return to its original condition. The protein function is also affected negatively because of the altered structured.

Conclusion The change in the L341F leads to serious structural defects in the tryptophan hydroxylase-2. Those defects can be further related with functional instability and associated to the etiology of neuropsychiatric diseases.

Keywords

polymorphism - serotonin - tryptophan hydroxylase - SNPs - amino acid

Author Contributions

This work was a coordinated effort of the four authors; we all participated in the analysis and draft of the manuscript. No activities breakdown was presented.

• References

• 1 Wang L, Erlandsen H, Haavik J, Knappskog PM, Stevens RC. Three-dimensional structure of human tryptophan hydroxylase and its implications for the biosynthesis of the neurotransmitters serotonin and melatonin. Biochemistry 2002; 41 (42) 12569-12574
• 2 Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int J Tryptophan Res 2009; 2: 45-60
• 3 Martínez A, Knappskog PM, Haavik J. A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis. Curr Med Chem 2001; 8 (09) 1077-1091
• 4 Santibáñez L, Ortiz R, Guzmán O. , et al. Expresión de la triptófano hidroxilasa en tallo cerebral de ratas con restricción alimenticia. BIOLÓGICAS; 2008
• 5 Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacol Rev 2012; 64 (02) 359-388
• 6 Zhang X, Gainetdinov RR, Beaulieu JM. , et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005; 45 (01) 11-16
• 7 Zhang Y, Zhang C, Yuan G. , et al. Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression. Behav Brain Funct 2010; 6: 49
• 8 Acosta-Hernández M, Mancilla-Percino T, Correa-Basurto J. , et al. Depresión en la infancia y adolescencia: enfermedad de nuestro tiempo. Archivos Neurociencias 2011; 18 (01) 20-25
• 9 Bardin L. The complex role of serotonin and 5-HT receptors in chronic pain. Behav Pharmacol 2011; 22 (5-6): 390-404
• 10 Ostrosky-Solis F. Características neuropsicológicas de la enfermedad de Parkinson. Rev Neurol 2000; 30 (08) 788-796
• 11 Urbina M, Lavie R, Resler G, Campos J, Mata S, Lima L. Síntesis de serotonina y presencia de hidroxilasa de triptófano en linfocitos de pacientes con depresión mayor tratados con fluoxetina y ácido fólico. Arch Venez Farmacol Ter 2008; 27: 114-120